IPO Report: ContraFect (CFRXU)
Equities.com ContraFect (CFRXU) is a biotechnology company focused on discovering and developing therapeutic protein and antibody products for life-threatening, drug-resistant infectious diseases. It is headquartered in Yonkers, N.Y.. Nineteen other companies are … |
Subscriber Content
After subscribing to the service (All Levels) this menu will become active to direct you to member database locations and weekly audio recordings. Please refresh the page if you have subscribed and are still seeing this message.




